<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "JATS-journalpublishing1.dtd">
<article article-type="abstract" dtd-version="1.0" xml:lang="en" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">CC</journal-id>
<journal-id journal-id-type="nlm-ta">Cardiol Croat</journal-id>
<journal-title-group>
<journal-title>Cardiologia Croatica</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Cardiol. Croat.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="ppub">1848-543X</issn>
<issn pub-type="epub">1848-5448</issn>
<publisher><publisher-name>Croatian Cardiac Society</publisher-name></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">CC_13(11-12)_309</article-id>
<article-id pub-id-type="doi">10.15836/ccar2018.309</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Extended Abstract</subject></subj-group>
</article-categories>
<title-group>
<article-title>Risk factors for acute ST-segment elevation myocardial&#x2028;infarction in young patients</article-title>
<trans-title-group xml:lang="HR">
<trans-title>Rizi&#x010D;ni &#x010D;imbenici za akutni infarkt miokarda s elevacijom&#x2028;ST-segmenta u mladih bolesnika</trans-title>
</trans-title-group>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5519-439X</contrib-id><name><surname>Pu&#x0161;kari&#x0107;</surname><given-names>Filip</given-names></name><xref ref-type="corresp" rid="cor1">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4772-5549</contrib-id><name><surname>&#x010C;ike&#x0161;</surname><given-names>Maja</given-names></name></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1762-9270</contrib-id><name><surname>Ostoji&#x0107;</surname><given-names>Zvonimir</given-names></name></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3197-2190</contrib-id><name><surname>Pa&#x0161;ali&#x0107;</surname><given-names>Marijan</given-names></name></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0561-6704</contrib-id><name><surname>Planinc</surname><given-names>Ivo</given-names></name></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1482-6503</contrib-id><name><surname>Bulum</surname><given-names>Jo&#x0161;ko</given-names></name></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9101-1570</contrib-id><name><surname>Mili&#x010D;i&#x0107;</surname><given-names>Davor</given-names></name></contrib>
<aff id="aff1">Medicinski fakultet Sveu&#x010D;ili&#x0161;ta u Zagrebu, Klini&#x010D;ki bolni&#x010D;ki centar Zagreb, Zagreb, Hrvatska</aff>
<aff id="aff2">University of Zagreb School of Medicine, <institution>University Hospital Centre Zagreb</institution>, <addr-line>Zagreb</addr-line>, <country>Croatia</country></aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>*</label>ADDRESS FOR CORRESPONDENCE: Filip Pu&#x0161;kari&#x0107;, Klini&#x010D;ki bolni&#x010D;ki centar Zagreb, Ki&#x0161;pati&#x0107;eva 12, HR-10000 Zagreb, Croatia. / Phone: +385-99-7505-240 / E-mail: <email xlink:href="fpuskaric@gmail.com">fpuskaric@gmail.com</email></corresp></author-notes>
<pub-date pub-type="epub-ppub"><month>11</month><year>2018</year></pub-date>
<volume>13</volume>
<issue>11-12</issue>
<fpage>309</fpage>
<lpage>310</lpage>
<history>
<date date-type="received"><day>26</day><month>10</month><year>2018</year></date><date><day>05</day><month>11</month><year>2018</year></date>
</history>
<permissions>
<copyright-year>2018</copyright-year>
<copyright-holder>Croatian Cardiac Society</copyright-holder>
</permissions>
<kwd-group kwd-group-type="translator" xml:lang="HR"><kwd>KLJU&#x010C;NE RIJE&#x010C;I: akutni koronarni sindrom</kwd><kwd>STEMI</kwd><kwd>mladi bolesnici</kwd></kwd-group>
<kwd-group kwd-group-type="author"><title>KEYWORDS: </title><kwd>acute coronary syndrome</kwd><kwd>STEMI</kwd><kwd>young patient</kwd></kwd-group>
</article-meta>
</front>
<body>
<p><bold>Introduction:</bold> Acute coronary syndrome (ACS), including acute ST-segment elevation myocardial infarction (STEMI), is more prevalent in older patients (pts), leading to fewer studies with young pts. (<xref ref-type="bibr" rid="r1"><italic>1</italic></xref>) The age limit varies among studies, but a cut-off of 45 years (yr.) is the most common. Traditional differences described in the risk factors for younger compared to older pts. include a higher prevalence of smoking, family history of premature coronary heart disease (FH) and male gender.</p>
<p><bold>Patients and Methods:</bold> We performed a retrospective analysis of medical records of 164 pts. (mean age 43.9&#x00B1;6.5 yr.) hospitalized with STEMI at the University Hospital Centre Zagreb from January 2012 to October 2018, with a cut-off at 45 yr. for men (n=102) and 55 yr. (n=62) for women. Analyzed variables are listed in <xref ref-type="table" rid="t1"><bold>Table 1</bold></xref>. Body mass index (BMI, kg/m<sup>2</sup>) was interpreted as: &#x2264;18.5 (underweight), 18.6&#x2013;24.9 (normal), 25.0&#x2013;29.9 (overweight), &#x2265;30 (obese). Positive cardiovascular FH was defined as relatives with ACS, stable coronary artery disease (SCAD) or cerebrovascular disease.</p>
<table-wrap id="t1" position="float">
<label>TABLE 1</label><caption><title>Patients&#x2019; characteristics.</title>
</caption>
<table frame="hsides" rules="groups">
<col width="29.1%"/>
<col width="21.7%"/>
<col width="27.5%"/>
<col width="21.7%"/>
<thead>
<tr>
<th valign="top" align="left" scope="col" style="border-left: solid 0.75pt; border-top: solid 0.75pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt"><bold>Variable</bold></th>
<th valign="top" align="left" scope="col" style="border-left: solid 0.75pt; border-top: solid 0.75pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt"><bold>N (%)</bold></th>
<th valign="top" align="left" scope="col" style="border-left: solid 0.75pt; border-top: solid 0.75pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt"><bold>Variable</bold></th>
<th valign="top" align="left" scope="col" style="border-left: solid 0.75pt; border-top: solid 0.75pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt"><bold>N (%)</bold></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt" scope="row"><bold>Gender</bold></td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt"></td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt"><bold>Thyroid condition</bold></td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt"></td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt" scope="row">&#x00A0;&#x00A0;&#x00A0;Male</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt"><bold>102</bold> (62.2)</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">&#x00A0;&#x00A0;&#x00A0;Hypothyroidism</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt"><bold>8</bold> (4.9)</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt" scope="row">&#x00A0;&#x00A0;&#x00A0;Female</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt"><bold>62</bold> (37.8)</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">&#x00A0;&#x00A0;&#x00A0;Hyperthyroidism</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt"><bold>0</bold> (0)</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt" scope="row"><bold>BMI</bold></td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt"></td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt"><bold>Therapy at discharge</bold></td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt"></td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt" scope="row">&#x00A0;&#x00A0;&#x00A0;&lt;= 18.5</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt"><bold>0</bold> (0)</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">&#x00A0;&#x00A0;&#x00A0;Aspirin</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt"><bold>157</bold> (96.9)</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt" scope="row">&#x00A0;&#x00A0;&#x00A0;18.5 &#x2013; 24.9</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt"><bold>36</bold> (23.2)</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">&#x00A0;&#x00A0;&#x00A0;P2Y12 inhibitor</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt"></td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt" scope="row">&#x00A0;&#x00A0;&#x00A0;25.0 &#x2013; 29.9</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt"><bold>61</bold> (39.4)</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;Clopidogrel</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt"><bold>90</bold> (55.6)</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt" scope="row">&#x00A0;&#x00A0;&#x00A0;&gt;= 30.0</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt"><bold>58</bold> (37.4)</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;Ticagrelor</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt"><bold>67</bold> (41.4)</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt" scope="row"><bold>Smoking status</bold></td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt"></td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">&#x00A0;&#x00A0;&#x00A0;Beta blocker</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt"><bold>134</bold> (82.7)</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt" scope="row">&#x00A0;&#x00A0;&#x00A0;Non-smokers</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt"><bold>26</bold> (16.3)</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">&#x00A0;&#x00A0;&#x00A0;ACE inhibitor</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt"><bold>127</bold> (78.4)</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt" scope="row">&#x00A0;&#x00A0;&#x00A0;Former smokers</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt"><bold>9</bold> (5.6)</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">&#x00A0;&#x00A0;&#x00A0;ARB</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt"><bold>5</bold> (3.1)</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt" scope="row">&#x00A0;&#x00A0;&#x00A0;Current smokers</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt"><bold>125</bold> (78.1)</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">&#x00A0;&#x00A0;&#x00A0;MRA</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt"><bold>22</bold> (13.6)</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt" scope="row"><bold>Arterial hypertension</bold></td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt"><bold>80</bold> (49.4)</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">&#x00A0;&#x00A0;&#x00A0;Nitrate</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt"><bold>20</bold> (12.3)</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt" scope="row"><bold>Diabetes mellitus</bold></td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt"></td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">&#x00A0;&#x00A0;&#x00A0;Statin</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt"><bold>159</bold> (98.1)</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt" scope="row">&#x00A0;&#x00A0;&#x00A0;Type 1</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt"><bold>2</bold> (1.2)</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">&#x00A0;&#x00A0;&#x00A0;Antiischemic drug</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt"><bold>11</bold> (6.8)</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt" scope="row">&#x00A0;&#x00A0;&#x00A0;Type 2</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt"><bold>10</bold> (6.2)</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">&#x00A0;&#x00A0;&#x00A0;Factor Xa inhibitor</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt"><bold>40</bold> (24.7)</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt" scope="row"><bold>Therapy for diabetes mellitus</bold></td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt"></td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">&#x00A0;&#x00A0;&#x00A0;Antiarrhythmic</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt"><bold>17</bold> (10.5)</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt" scope="row">&#x00A0;&#x00A0;&#x00A0;Insulin</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt"><bold>3</bold> (1.9)</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">&#x00A0;&#x00A0;&#x00A0;Diuretic</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt"><bold>12</bold> (7.4)</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt" scope="row">&#x00A0;&#x00A0;&#x00A0;Oral hypoglycemics</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt"><bold>7</bold> (4.4)</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">&#x00A0;&#x00A0;&#x00A0;Heparin</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt"><bold>4</bold> (2.5)</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt" scope="row"><bold>Positive family history</bold></td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt"><bold>87</bold> (53.7)</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">&#x00A0;&#x00A0;&#x00A0;Vasodilator</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt"><bold>1</bold> (0.6)</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt" scope="row"></td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt"></td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">&#x00A0;&#x00A0;&#x00A0;Fibrate</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt"><bold>5</bold> (3.1)</td>
</tr>
<tr>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt" scope="row"></td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt"></td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt">&#x00A0;&#x00A0;&#x00A0;Warfarin</td>
<td valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.25pt"><bold>3</bold> (1.9)</td>
</tr>
<tr>
<td colspan="4" valign="top" align="left" style="border-left: solid 0.75pt; border-top: solid 0.25pt; border-right: solid 0.75pt; border-bottom: solid 0.75pt" scope="col">BMI = Body Mass Index; ACE = Angiotensin-Converting Enzyme; ARB = Angiotensin II Receptor Blocker; MRA = Mineralocorticoid Receptor Antagonist</td>
</tr>
</tbody></table></table-wrap>
<p><bold>Results:</bold> As seen in <xref ref-type="table" rid="t1"><bold>Table 1</bold></xref>, the majority of pts. were male (62.2%), had a high BMI (n=119; 76.8%), and were current smokers rather than former or non-smokers (78.1% vs 5.6% and 16.3%). The majority of pts. had positive FH (53.7%), whereas the minority had arterial hypertension (49.4%), diabetes mellitus (DM; 7.4%) and a thyroid condition (4.9%). In-hospital mortality was 0.6% (n=1), while 10.4% of pts. (n=17) required rehospitalization (rehosp.). The vast majority of rehosp. were due to ACS (64.7%), followed by SCAD (11.8%), arrhythmias (11.8%), heart failure (5.9%) and other causes (5.9%). A significant correlation was found between the need for rehosp. and the length of stay during hospitalization for the initial STEMI (OR=1.105, p=0.01), as well as with insulin-treated DM (OR=22.873, p=0.01).</p>
<p><bold>Conclusion:</bold> The most prominent risk factors in the studied population of young STEMI pts. were smoking, increased BMI and male gender. Roughly one out of ten pts. required rehosp., largely due to ACS, which mostly occurred in pts. with longer initial hospitalization lengths or those on insulin therapy. In-hospital mortality was noted in only one patient.</p>
</body>
<back>
<ref-list>
<title>LITERATURE</title>
<ref id="r1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shah</surname><given-names>N</given-names></name><name><surname>Kelly</surname><given-names>AM</given-names></name><name><surname>Cox</surname><given-names>N</given-names></name><name><surname>Wong</surname><given-names>C</given-names></name><name><surname>Soon</surname><given-names>K</given-names></name></person-group>. <article-title>Myocardial Infarction in the &#x201C;Young&#x201D;: Risk Factors, Presentation, Management and Prognosis.</article-title> <source>Heart Lung Circ</source>. <year>2016</year> Oct;<volume>25</volume>(<issue>10</issue>):<fpage>955</fpage>&#x2013;<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1016/j.hlc.2016.04.015</pub-id><pub-id pub-id-type="pmid">27265644</pub-id></mixed-citation></ref>
</ref-list>
</back>
</article>
